These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30691448)

  • 1. Modelling the impact of chest X-ray and alternative triage approaches prior to seeking a tuberculosis diagnosis.
    Shazzadur Rahman AAM; Langley I; Galliez R; Kritski A; Tomeny E; Squire SB
    BMC Infect Dis; 2019 Jan; 19(1):93. PubMed ID: 30691448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated chest-radiography as a triage for Xpert testing in resource-constrained settings: a prospective study of diagnostic accuracy and costs.
    Philipsen RH; Sánchez CI; Maduskar P; Melendez J; Peters-Bax L; Peter JG; Dawson R; Theron G; Dheda K; van Ginneken B
    Sci Rep; 2015 Jul; 5():12215. PubMed ID: 26212560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
    Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
    BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy study.
    Turner CT; Gupta RK; Tsaliki E; Roe JK; Mondal P; Nyawo GR; Palmer Z; Miller RF; Reeve BW; Theron G; Noursadeghi M
    Lancet Respir Med; 2020 Apr; 8(4):407-419. PubMed ID: 32178775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective diagnostic accuracy study.
    Reeve BW; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    medRxiv; 2023 Jun; ():. PubMed ID: 37333303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yield, Efficiency, and Costs of Mass Screening Algorithms for Tuberculosis in Brazilian Prisons.
    Santos ADS; de Oliveira RD; Lemos EF; Lima F; Cohen T; Cords O; Martinez L; Gonçalves C; Ko A; Andrews JR; Croda J
    Clin Infect Dis; 2021 Mar; 72(5):771-777. PubMed ID: 32064514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reassessment of the positive predictive value and specificity of Xpert MTB/RIF: a diagnostic accuracy study in the context of community-wide screening for tuberculosis.
    Ho J; Nguyen PTB; Nguyen TA; Tran KH; Van Nguyen S; Nguyen NV; Nguyen HB; Luu KB; Fox GJ; Marks GB
    Lancet Infect Dis; 2016 Sep; 16(9):1045-1051. PubMed ID: 27289387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis.
    van't Hoog AH; Cobelens F; Vassall A; van Kampen S; Dorman SE; Alland D; Ellner J
    PLoS One; 2013; 8(12):e82786. PubMed ID: 24367555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children.
    Kay AW; González Fernández L; Takwoingi Y; Eisenhut M; Detjen AK; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013359. PubMed ID: 32853411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study.
    Choun K; Decroo T; Mao TE; Lorent N; Gerstel L; Creswell J; Codlin AJ; Lynen L; Thai S
    Glob Health Action; 2019; 12(1):1646024. PubMed ID: 31500551
    [No Abstract]   [Full Text] [Related]  

  • 13. Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.
    Shapiro AE; Ross JM; Yao M; Schiller I; Kohli M; Dendukuri N; Steingart KR; Horne DJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013694. PubMed ID: 33755189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
    Ananthakrishnan R; Thiagesan R; Auguesteen S; Karunakaran N; Jayabal L; M J; Stevens R; Codlin A; Creswell J
    PLoS One; 2020; 15(11):e0241203. PubMed ID: 33147240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening tests for active pulmonary tuberculosis in children.
    Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Performance of Computer-Aided Detection Digital Chest X-ray Reading Technologies for Triage of Active Tuberculosis Among Persons With a History of Previous Tuberculosis.
    Kagujje M; Kerkhoff AD; Nteeni M; Dunn I; Mateyo K; Muyoyeta M
    Clin Infect Dis; 2023 Feb; 76(3):e894-e901. PubMed ID: 36004409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses.
    Kendall EA; Kamoga C; Kitonsa PJ; Nalutaaya A; Salvatore PP; Robsky K; Nakasolya O; Mukiibi J; Isooba D; Cattamanchi A; Kato-Maeda M; Katamba A; Dowdy DW
    PLoS One; 2019; 14(7):e0220251. PubMed ID: 31339935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study.
    Reeve BWP; Ndlangalavu G; Mishra H; Palmer Z; Tshivhula H; Rockman L; Naidoo S; Mbu DL; Naidoo CC; Derendinger B; Walzl G; Malherbe ST; van Helden PD; Semitala FC; Yoon C; Gupta RK; Noursadeghi M; Warren RM; Theron G
    Lancet Glob Health; 2024 May; 12(5):e793-e803. PubMed ID: 38583458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.